health.economictimes.indiatimes.com Open in urlscan Pro
2600:1417:3f:29c::3126  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Sign in/Sign up
 * Overview
 * Key Focus Sector
 * Speakers
 * Agenda
 * Discussion Points
 * Who Should Attend
 * Past Edition Glimpses
 * Contact Us
 * FAQ


PHARMA CONFERENCE AND EVENTS - ETPHARMA BIOMOLECULE WORKSHOP

27th April, 2024 | Hilton Mumbai International Airport
Register NowJoin As Partner


PARTNERS

ASSOCIATE PARTNER

EXHIBIT PARTNER


2+ DEEP-DIVE WORKSHOPS & CASE STUDIES


1INTERACTIVE PANEL DISCUSSION


5+SESSIONS


11+INDUSTRY THOUGHT-LEADERS & RESEARCHERS


60+ATTENDEES


OVERVIEW

The synthetic peptides, oligonucleotides, and mRNA market is a rapidly expanding
sector within the biomolecule industry, driven by advancements in synthesis
technologies and the growing demand for personalized medicine. These
custom-designed molecules play crucial roles in therapeutics, diagnostics, and
research, offering promising avenues for innovation and investment. 

The ETPharma Biomolecule Workshop & Connect brings together experts to delve
into recent progress, challenges, and prospects in synthetic peptides,
oligonucleotides, and mRNA. The event explores their immunogenicity, diverse
applications, and pivotal role in therapeutic breakthroughs, providing valuable
insights into pioneering research and cutting-edge technologies shaping the
future of healthcare.


KEY FOCUS SECTORS

 * Biopharmaceuticals
 * Biotechnology
 * Healthcare and Pharmaceutical Services
 * Life Sciences Research






GUEST SPEAKER

DR. HARISH CHANDER

Deputy Director (Q.C.), National Institute of Biologicals



KEYNOTE SPEAKER

DR. MANOJ PANANCHUKUNNATH

Chief Scientific Officer, Biocon Limited



SPEAKERS

PROF. DR. HOSAHUDYA N. GOPI

Professor of Chemistry., IISER Pune

DR. RAVI SHAH

Associate Professor, National Institute of Pharmaceutical Education and Research

DR. RAVI SHANKARA

Senior General Manager R&D, Sun Pharma

PROFESSOR ASHUTOSH KUMAR, STRUCTURAL BIOLOGY

Department of Bioscience and Bioengineering,, Indian Institute of Technology
Bombay,

DR. TATHAGATA DUTTA

President & Chief Technology Officer, JODAS EXPOIM PVT LTD

DR. MURALIDHARAN CHANDRAKESAN

Vice President, Aurobindo Pharma

DR. RAJESH BAHEKAR

Senior General Manager , Medicinal Chemistry , New Drug Discovery, Zydus Cadila

DR. AJAY SINGH

Head - mRNA, Gennova Biopharmaceuticals

DR. MANOJ METTA

Lead Scientist - Global Biologics, US Pharmacopeia

ROHIT JADHAV

General Manager, Analytical R&D, Kashiv Biosciences LLC

ASIS SINGH

Nucleic Acid Therapy Workflow Specialist - India, Cytiva



AGENDA

 * Day 1

 * 10:00 AM – 10:05 AM
   
   
   OPENING REMARKS - ETPHARMA

 * 10:05 AM – 10:35 AM
   
   
   GUEST ADDRESS : EXPLORING CRITICAL QUALITY ATTRIBUTES (CQAS) IN COMPLEX
   BIOPHARMACEUTICALS
   
   
   DR. HARISH CHANDER
   
   Deputy Director (Q.C.), National Institute of Biologicals

 * + 10:35 AM – 11:15 AM
   
   
   KEYNOTE SESSION: CRACKING THE CODE OF COMPLEX PHARMACEUTICALS: EXPLORING
   CRITICAL QUALITY ATTRIBUTES IN PEPTIDES AND OLIGONUCLEOTIDES (CQA‘S & PQA’S)
   
   Cracking the Code of Complex Pharmaceuticals: Exploring Critical Quality
   Attributes in Peptides and Oligonucleotides (CQA‘s & PQA’s)
   
   
   DR. MANOJ PANANCHUKUNNATH
   
   Chief Scientific Officer, Biocon Limited

 * 11:15 AM – 11:35 AM
   
   
   OLIGONUCLEOTIDES THERAPEUTICS - A FULL OLIGO WORKFLOW FOR PROCESS DEVELOPMENT
   AND BEYOND
   
   
   ASIS SINGH
   
   Nucleic Acid Therapy Workflow Specialist - India, Cytiva

 * 11:35 AM – 12:00 PM
   
   
   NETWORKING COFFEE BREAK

 * + 12:00 PM – 12:40 PM
   
   
   CURRENT CHALLENGES AND REGULATORY INSIGHTS IN ASSESSMENT OF IMMUNOGENICITY OF
   PEPTIDE PRODUCTS
   
   
   
   
   DR. RAVI SHANKARA
   
   Senior General Manager R&D, Sun Pharma

 * 12:40 PM – 01:15 PM
   
   
   ENSURING PURITY AND SAFETY: INNOVATIONS IN BIOMOLECULE IMPURITY
   CHARACTERIZATION
   
   
   PROF. DR. HOSAHUDYA N. GOPI
   
   Professor of Chemistry., IISER Pune

 * 01:15 PM – 02:10 PM
   
   
   NETWORKING LUNCH BREAK

 * 02:10 PM – 02:50 PM
   
   
   QUALITY ASSESSMENT OF OLIGONUCLEOTIDES : CHALLENGES & OPPORTUNITIES
   
   
   DR. RAVI SHAH
   
   Associate Professor, National Institute of Pharmaceutical Education and
   Research

 * 02:50 PM – 03:30 PM
   
   
   CASE STUDY: MRNA VACCINE FROM CONCEPT TO CLINIC
   
   
   DR. AJAY SINGH
   
   Head - mRNA, Gennova Biopharmaceuticals

 * 03:30 PM – 03:50 PM
   
   
   NETWORKING COFFEE BREAK

 * 03:50 PM – 04:35 PM
   
   
   ZOOMING INSIDE HOS OF IN-FORMULATION STATE BIOPHARMACEUTICALS BY NMR
   SPECTROSCOPY
   
   
   PROFESSOR ASHUTOSH KUMAR, STRUCTURAL BIOLOGY
   
   Department of Bioscience and Bioengineering,, Indian Institute of Technology
   Bombay,

 * 04:35 PM – 05:25 PM
   
   
   PANEL DISCUSSION: HARMONIZING PROGRESS: CATALYZING BIOMOLECULE ADVANCEMENTS
   THROUGH TRI-SECTOR COLLABORATION (ACADEMIA,REGULATORY BODIES AND INDUSTRY)
   
   
   DR. TATHAGATA DUTTA
   
   President & Chief Technology Officer, JODAS EXPOIM PVT LTD
   
   
   ROHIT JADHAV
   
   General Manager, Analytical R&D, Kashiv Biosciences LLC
   
   
   DR. MURALIDHARAN CHANDRAKESAN
   
   Vice President, Aurobindo Pharma
   
   
   DR. RAJESH BAHEKAR
   
   Senior General Manager , Medicinal Chemistry , New Drug Discovery, Zydus
   Cadila
   
   
   DR. MANOJ METTA
   
   Lead Scientist - Global Biologics, US Pharmacopeia

 * 05:25 PM – 05:30 PM
   
   
   CLOSING REMARKS


DISCUSSION POINTS

 * Regulatory Evolution: Navigating Approval Strategies for Novel Therapeutics -
   Oligonucleotides, Peptides, and mRNA
 * Ensuring Purity and Safety: Innovations in Biomolecule Impurity
   Characterization
 * Maximizing Therapeutic Potential: Peptide-Oligonucleotide Hybrids and
   Conjugates in Novel Therapeutics
 * Exploring the Pharmacokinetics of Peptides and Oligonucleotides: Absorption,
   Distribution, Metabolism, and Excretion (ADME)
 * From Bench to Bedside: Oligonucleotide Drug Delivery Innovations and Clinical
   Triumphs
 * Cracking the Code of Complex Pharmaceuticals: Exploring Critical Quality
   Attributes in Peptides and Oligonucleotides (CQA’s & PQA’s)
 * Harmonizing Progress: Catalyzing Biomolecule Advancements through Tri-Sector
   Collaboration (Academia, Regulatory bodies and Industry Stakeholders)
 * Encasing Efficacy: The Vital Synergy Between Packaging and Delivery Systems
   in Peptide Therapeutics
 * Virtual Visions: Harnessing In Silico Innovations for Biomolecules – From
   Design to Therapeutic Impact




WHO SHOULD ATTEND

 * Research and Development (R&D)
 * Contract Manufacturing
 * Drug Discovery and Development
 * Manufacturing & Process Development
 * Quality Assurance & Quality Control
 * Researchers and Scientists
 * Analytical Development
 * Pharmaceutical and Biotech Industry Professionals
 * Contract Research
 * Regulatory and Compliance Experts




REGISTRATION FEE

Delegate Pass for Drug Developers Delegate Pass for Academics & Research
Institutes Delegate Pass for Service / Solution Providers Early Bird Offer
Regular Price 12000 + Taxes 60000 + Taxes (Till 2nd April 2024) (Till 27th April
2024) 7000 + Taxes 11000 + Taxes Buy Now Above mentioned registration fee is
exclusive of 18% GST

*Group Nominations* 10% discount 3 delegates 15% discount 5+ delegates ***Please
note that discounts are only valid when three or more delegates from one company
book and pay at the same time.


PREVIOUS EDITION GLIMPSES

Previous

Next
 * 1
 * 2
 * 3
 * 4
 * 5
 * 6
 * 7
 * 8
 * 9
 * 10
 * 11
 * 12
 * 13
 * 14
 * 15
 * 16
 * 17
 * 18
 * 19
 * 20


CONTACT US

For Conference Queries
Roopali Bhandari
roopali.bhandari@timesinternet.in +918355886009
Anish Nikharge
anish.nikharge@timesinternet.in +918550990707

For any issues requiring immediate escalation, please write to
shahbaz.khan@timesinternet.in - Md. Shahbaz Khan, Head of Special Initiatives &
Business Strategy, The Economic Times Business Verticals.


FAQ


WHAT IS THE ETPHARMA BIOMOLECULE WORKSHOP & CONNECT?

The Biomolecule Workshop & Connect by ET Pharma is an exclusive industry event
that brings together professionals and experts from the pharmaceutical and
biotech sectors. It offers a platform for knowledge sharing, discussions on the
latest advancements in synthetic peptides and oligonucleotides, and valuable
networking opportunities.


WHAT IS THE AGENDA OF THIS BIOMOLECULE WORKSHOP & CONNECT?

The agenda for the Biomolecule Workshop & Connect encompasses a wide range of
topics including exploring regulatory evolution, pharmacokinetics, tri-sector
collaboration, impurity characterization, drug delivery innovations, packaging
synergy, and more, all aimed at maximizing therapeutic potential and fostering
industry advancement.


WHEN & WHERE IS THE PHARMA WORKSHOP & CONNECT TAKING PLACE?

The Biomolecule Pharma Workshop & Connect is scheduled to take place on April
27, 2024, in Mumbai.


WHAT IS THE REGISTRATION COST FOR THE PHARMACEUTICAL WORKSHOP AND WHAT IS
INCLUDED?

The registration cost for the workshop varies. Please visit our event to view
the current pricing details and what's included in the registration package.


HOW IS IT BENEFICIAL TO JOIN THE ET PHARMA BIOMOLECULE WORKSHOP?

Joining the ET Pharma Workshop is highly beneficial as it provides a unique
opportunity to gain insights from industry experts, stay updated on the latest
trends and advancements, establish valuable connections with peers, and
contribute to discussions that are shaping the future of synthetic peptides and
oligonucleotides in the pharmaceutical industry. It's an enriching experience
that can significantly enhance your knowledge and professional network within
the field.


ARE THERE ANY DISCOUNTS AVAILABLE FOR THE ET PHARMA CONFERENCE & SUMMIT?

Yes, we offer exclusive early bird discounts for those who register on or before
2nd April 2024. Additionally, group discounts are available for three or more
delegates from the same company who book and pay at the same time. Check our
registration page for the latest discount information.


ETPHARMA

ETPharma, an exceptional digital initiative within the ETHealthworld umbrella,
serves as a trusted resource for the discerning pharmaceutical industry
audience. With comprehensive coverage of Drug Development, Clinical Trials,
Regulatory Affairs, Pricing, Manufacturing, Packaging and Distribution, ETPharma
has become the go-to platform for professionals, researchers, policymakers, and
patients alike. ETPharma provides insightful commentary, astute analysis, and
expert opinions from industry leaders, empowering readers to stay ahead of the
latest trends and developments

Register Now

For any issues requiring immediate escalation, please write to
shahbaz.khan@timesinternet.in - Md. Shahbaz Khan,
Head of Special Initiatives & Business Strategy, The Economic Times Business
Verticals


EVENTS

 * NutriWell Business Conclave | 23 Feb '24
 * Future-Ready Pharma Supply Chain Summit 2024
 * Fertility Conclave 2023 4th Edition
 * Re Pharma Summit | 19 Jan '24

 * About Us
 * Contact Us
 * Advertise with us
 * Newsletter
 * RSS Feeds
 * Invite Friends
   

 * Privacy Policy
 * Terms & Conditions
 * Guest-Post Guidelines
 * Sitemap
 * Embed ETHealthworld.com Widgets on your Website

Copyright © 2024 ETHealthworld.com . All Rights Reserved.




PRIVACY PREFERENCE CENTER

When you visit any website, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalized web experience. Because we respect your right to
privacy, you can choose not to allow some types of cookies. Click on the
different category headings to find out more and change our default settings.
However, blocking some types of cookies may impact your experience of the site
and the services we are able to offer.
More information
Allow All


MANAGE CONSENT PREFERENCES

PERFORMANCE COOKIES

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site. All
information these cookies collect is aggregated and therefore anonymous. If you
do not allow these cookies we will not know when you have visited our site, and
will not be able to monitor its performance.

FUNCTIONAL COOKIES

Functional Cookies

These cookies enable the website to provide enhanced functionality and
personalisation. They may be set by us or by third party providers whose
services we have added to our pages. If you do not allow these cookies then some
or all of these services may not function properly.

STRICTLY NECESSARY COOKIES

Always Active

These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms. You can set your browser to block
or alert you about these cookies, but some parts of the site will not then work.
These cookies do not store any personally identifiable information.

TARGETING COOKIES

Targeting Cookies

These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites. They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.

Back Button


COOKIE LIST



Search Icon
Filter Icon

Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label

Reject All Confirm My Choices